Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
McKesson
Boehringer Ingelheim
Baxter
Harvard Business School

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for keyhole limpet hemocyanin

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug keyhole limpet hemocyanin?

keyhole limpet hemocyanin is an investigational drug.

There have been 29 clinical trials for keyhole limpet hemocyanin. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2011.

The most common disease conditions in clinical trials are Glioblastoma, Lymphoma, and Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID), and John Sampson.

Recent Clinical Trials for keyhole limpet hemocyanin
TitleSponsorPhase
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent GlioblastomaMount Sinai Hospital, New YorkPhase 2
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent GlioblastomaNew York University School of MedicinePhase 2
Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/AdjuvantPCI Biotech ASPhase 1

See all keyhole limpet hemocyanin clinical trials

Clinical Trial Summary for keyhole limpet hemocyanin

Top disease conditions for keyhole limpet hemocyanin
Top clinical trial sponsors for keyhole limpet hemocyanin

See all keyhole limpet hemocyanin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Johnson and Johnson
McKinsey
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.